PB2331: AN ONGOING FIRST-IN-HUMAN PHASE 1 TRIAL OF NX-5948, AN ORAL BRUTON’S TYROSINE KINASE (BTK) DEGRADER, IN PATIENTS WITH RELAPSED/REFRACTORY B CELL MALIGNANCIES

Detalles Bibliográficos
Autores principales: Linton, Kim, Doorduijn, Jeanette, El-Sharkawi, Dima, Mous, Rogier, Forconi, Francesco, Lewis, David, Gleeson, Mary, Riches, John, Mckay, Pam, Stevens, Wendy, Injac, Sarah G, Collins, Graham P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428890/
http://dx.doi.org/10.1097/01.HS9.0000976044.29005.fd
Descripción
Sumario:

Ejemplares similares